Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sánchez-Cuéllar, H. de La Fuente, A. Lamana, D. Cibrián, A. Cruz-Adalia, R. M. Girón, F. Sánchez-Madrid, J. Ancochea (Madrid, Spain). Expresion of galectins in asthma patients. Eur Respir J 2011; 38: Suppl. 55, 477

Member's Comments

No comment yet.

Related content which might interest you: Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 Régulation de l'inflammation dans l'asthme : IL37 vs IL17Inflammatory regulation in asthma: IL37 vs IL17 Source: International Congress 2017 – French Programme 2017 Year: 2017 Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD Source: Virtual Congress 2020 – French programme 2020: Part II Year: 2020 Comparison of efficacy of grippe vaccination in asthma and COPD patients Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Cost of chronic allergic rhinitis: French exemple Source: Eur Respir J 2003; 22: Suppl. 45, 116s Year: 2003 COPD: the Italian recommendationBPCO: le raccomandazioni Italiane Source: International Congress 2017 – ERS Italian Day programme Year: 2017 Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care Source: International Congress 2017 – French Programme 2017 Year: 2017 Occupational asthma in France: a 1-yr report of the Observatoire National de Asthmes Professionnels project Source: Eur Respir J 2002; 19: 84-89 Year: 2002 Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension Source: International Congress 2016 – ERS/French Programme II Year: 2016 Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done? Source: Virtual Congress 2021 – French programme 2021 Year: 2021 Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment Source: International Congress 2016 – ERS/French Programme I Year: 2016 Nouvelles perspectives thérapeutiques dans la tuberculose multi-résistanteNew perspectives in the treatment of MDR-TB Source: International Congress 2016 – ERS/French Programme II Year: 2016 La simvastatina no inhibe la inflamación producida por las células pulmonares Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last ! Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Evolution of the psychometric dimensions of the VQ11 questionnaire in COPD patients undergoing a pulmonary rehabilitation program (PRP). Results from the French cohort Rehaeffort from IRSR des Pays de Loire Source: International Congress 2016 – Latest insights into pulmonary rehabilitation Year: 2016 Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications Source: Virtual Congress 2021 – French programme 2021 Year: 2021